Amaqiniso nobuqili mayelana nomuthi odumile wamagciwane
I-Tamiflu (i-oseltamivir) yisidakamizwa esithandwayo, esilula ngomlomo esetshenziselwa ukuphatha noma ukuvimbela umkhuhlane (umkhuhlane) . Kuvunyiwe yi-US Food and Drug Administration (FDA) ukuphatha izingane ezinamaviki amabili noma ngaphezulu futhi ukuvimbela umkhuhlane kubantwana izinyanga ezintathu noma ngaphezulu.
Naphezu kokuthandwa kwayo, ukusetshenziswa kukaTamiflu ezinganeni kuhlala kungavumelani.
Kuyinto evamile ukuzwa abazali bethi akusebenzi ngaso sonke isikhathi noma ukufunda imibiko ebonisa ukuthi ukusetshenziswa ngokweqile kungaholela ekuthuthukisweni kwezinkinga zemithonjeni elwa nemithi .
Ucwaningo luyasitshelani ngempela?
Izinzuzo Zokuthatha iTamiflu
Ngokusho kombiko ovela kwiCenter for the Disease Control and Prevention (CDC), ukusetshenziselwa kwezidakamizwa ze-antiviral ekuqaleni kukaTamiflu kunganciphisa isikhathi sempawu zamagciwane, kuhlanganise nomkhuhlane, futhi kunganciphisa ingozi yezinkinga (kuhlanganise ne-pneumonia, ukwehluleka ukuphefumula, nokufa).
I-Tamiflu ingenye yezidakamizwa ezintathu ezivimbela i-antiviaral ezivunyelwe ukusetshenziswa kwalokhu, okubandakanya nezidakamizwa ze- Rapivab (peramivir) nezidakamizwa ezingenayo i-Relenza (zanamivir) . Ngokungafani nezinye izinhlobo zokulwa namagciwane ezisetshenziselwa ukwelapha umkhuhlane, lezi zidakamizwa ezintathu ziphumelela ekuphatheni kokubili i-influenza A kanye namagciwane e-influenza B.
I-Tamiflu ibalulekile nakancane ezinganeni ezingenakukwazi ukuthola umkhuhlane , njengalabo abaye babhekana nesifo sokugoma emndenini wokugoma.
Ukwehla kokuthatha iTamiflu
Naphezu kobufakazi obusekela ukusetshenziswa kukaTamiflu ezinganeni, kunemithango eminingi eye yavimbela abazali ukuba bayisebenzise. Inani liyinhloko phakathi kokukhathazeka, ngeklasi lezinsuku ezinhlanu lokusebenza eliphakeme njenge $ 100. Ngenkathi izindleko eziphansi ezakhiwe manje sezikhona, intengo isabalulekile.
Ngokuphathelene nokho nokho inkolelo yokuthi lesi sidakamizwa asisebenzi ngempela. Ezimweni eziningi, lokhu kuhlotshaniswa nokunye okusetshenziselwa ukusetshenziswa kabi komkhiqizo kunomuthi ngokwawo.
Ukukhuluma ngokweqile, ukuphumelela kukaTamiflu kungahluka uma ukwelashwa kuqalwa. Ukuze kube sekugcineni, odokotela abaningi batusa ukuthi lesi sidakamizwa sithathwe zingakapheli amahora angu-24 kokuqala kokubonakala kwezimpawu. Inkinga, yilokho ukuthi abazali ngezinye izikhathi bangaphuthelwa izimpawu ezincane ezinjengezinyosi noma umphimbo oqhakazile, ikakhulukazi uma ingane ibonakala ingenjalo kahle.
Ngaphezu kwalokho, lesi sidakamizwa ngeke "sibulale" igciwane uma ukutheleleka kwenzekile kodwa kuncishiswe ubude nobukhulu bezimpawu.
Ngakolunye uhlangothi, uTamiflu ingaba yimpumelelo kakhulu emntwaneni engakaqotjelwa futhi iye yazungeze ezinye izingane ezinomkhuhlane. Kodwa-ke, ngoba izinzuzo zibonakala zingabonakali, abazali bazovame ukuwusebenzisa ekusetshenzisweni komkhuhlane futhi bafinyelele kuphela lapho izimpawu zivela.
I-Tamiflu Side Effects
Ngokuvamile umzali uhlobanisa intengo nge-potency nokwesaba ukuthi umuthi onjengeTamiflu ungabangela izimpawu eziningi kunokuba zikhulule. Ngokuyinhloko, lokhu akuyiqiniso.
Ngokusho kwe-FDA, imiphumela emibili ejwayelekile kakhulu iyisicasuli nokuhlanza, ngokuvamile akuyona yonke into enzima futhi kwenzeka ezinsukwini ezimbili kokuqala ukwelashwa Ukuthatha i-Tamiflu ngokudla kunganciphisa ingozi yale miphumela emibi.
Ezinye zingabandakanya ubuhlungu besisu, izinkinga ze-nosebleeds, izinwele, nokukhathala.
Imiphumela emibi kakhulu yabikwa. Ucwaningo olulodwa eJapane lwalusikisela ukuthi uTamiflu ukwandisa ingozi yezimpawu ze-neuropsychiatric ezifana nokudideka nokucabangela futhi kungaholela emicabangweni yokuzilimaza noma ukuzibulala ezinganeni. Lokhu kwalandela imibiko ngo-2005 ukuthi intsha embili yazibulala ngemuva nje kokusebenzisa lesi sidakamizwa.
Kuze kube manje, azikho izenzakalo ezifanayo ezibikiwe, futhi, kusukela kumbono womhlaba jikelele, ukuhlaziywa kwamakethe okuthunyelwe akutholakanga nengozi enkulu yokwenza imiphumela ye-neuropsychiatric kubasebenzisi. Uma kuthiwa, ukulayishwa komkhiqizo olusha kuhlanganisa ukululekwa ukuthi ukuhlelwa, ukulimala, nokuziphatha okungavamile, kuyilapho kungavamile kakhulu, kungenzeka.
Ukukhathazeka Ngokumelene Nokumelana noTamiflu
Njengama-antibiotics asetshenziselwa ukwelapha ukutheleleka kwebhaktheriya, kuye kwaba nokukhathazeka okwesikhathi eside ukuthi ukusetshenziswa okujwayelekile kwemithi yokwelapha i-antiviral kungabangela ekuthuthukiseni kwe-supervirus.
Kuze kube manje, asikaboni lokhu. Ngokusho kwe-CDC, ukumelana noTamiflu kubonakala ngenye indlela yegciwane le-H1N1 ngonyaka ka-2009 kodwa ngamaphesenti ayisisodwa kuphela samasampuli. Ngenxa yalokho, i-CDC ibheka njengengozi ephansi kepha iyaqhubeka iqapha uma kwenzeka izigameko zanda.
Kusukela manje, ukumelana nezinye izinkinga zegciwane lesifo sengculazi A noma B akukaze kubonwe.
> Imithombo:
> Amasevisi Okulawula Nokuvimbela Izifo. "Umkhuhlane we-Influenza Antiviral Medication: Summary for Clinicians." I-Atlanta, Georgia; ibuyekeziwe ngo-Okthoba 26, 2017.
> Fiore, A .; Fry, A .; Shay, D. et al. "Amagciwane Antiviral for the Treatment and Chemoprophylaxis of Influenza: Izincomo zeKomidi Elilulekayo Emisebenzini Yokugoma (ACIP)." I-MMWR. NgoJanuwari 21, 2011; 60 (RR01): 1-24. I-PMID: 21248682.
> Ukuphathwa Kwezokudla Nezidakamizwa zase-US. "Tamiflu Pediatric Izenzakalo ezimbi: Imibuzo nezimpendulo." I-Silver Spring, e-Maryland; ibuyekeziwe ngomhla kaDisemba 7, 2015.